| |
 |
Editorial [Hot Topic:Imaging and Treatment of Oncological Diseases (Guest Editor: J.F.W. Nijsen)]
 |
| |
|
pp.269-269 (1) Author: Frank (Johannes Franciscus Wilhelmus) Nijsen |
| |
|
|
| |
|
The Bright Future of Radionuclides for Cancer Therapy
|
| |
|
pp.271-290 (20) Authors: Johannes Franciscus Wilhelmus Nijsen, Gerard Cornelis Krijger, Afred Dirk van het Schip |
| |
|
|
| |
|
MRI Contrast Agents: Current Status and Future Perspectives
|
| |
|
pp.291-305 (15) Authors: Gustav J. Strijkers, Willem J. M. Mulder, Geralda A. F. van Tilborg, Klaas Nicolay |
| |
|
|
| |
|
Contrast Agents in X-Ray Computed Tomography and Its Applications in Oncology
|
| |
|
pp.307-316 (10) Authors: Annemarieke Rutten, Mathias Prokop |
| |
|
|
| |
|
Factors Affecting the Sensitivity and Detection Limits of MRI, CT, and SPECT for Multimodal Diagnostic and Therapeutic Agents
|
| |
|
pp.317-334 (18) Authors: Peter R. Seevinck, Jan-Henry Seppenwoolde, Tim C. de Wit, Johannes F. W. Nijsen, Freek J. Beekman, Alfred D. van het Schip, Chris J. G. Bakker |
| |
|
|
| |
|
Radionuclide Therapy of Cancer with Radiolabeled Antibodies
|
| |
|
pp.335-343 (9) Authors: Wim J. Oyen, E. J. Postema, Frans H. Corstens, Otto C. Boerman, Manuel J. Koppe |
| |
|
|
| |
|
Radiolabelled Regulatory Peptides for Imaging and Therapy
|
| |
|
pp.345-357 (13) Authors: M. de Jong, T. J. Visser, E. de Blois, W. A. P. Breeman, D. J. Kwekkeboom, E. P. Krenning |
| |
|
|
| |
|
Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy
|
| |
|
pp.359-365 (7) Authors: Yuki Ishii, Samuel Waxman, Doris Germain |
| |
|
|
| |
|
Labeling Biomolecules with Radiorhenium - A Review of the Bifunctional Chelators
|
| |
|
pp.367-377 (11) Authors: Guozheng Liu, Donald J. Hnatowich |
| |
|
|
